These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 15846919

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Direct genotyping of animal and human isolates of Toxoplasma gondii from Colombia (South America).
    Gallego C, Saavedra-Matiz C, Gómez-Marín JE.
    Acta Trop; 2006 Feb; 97(2):161-7. PubMed ID: 16310753
    [Abstract] [Full Text] [Related]

  • 29. Use of SAG2A recombinant Toxoplasma gondii surface antigen as a diagnostic marker for human acute toxoplasmosis: analysis of titers and avidity of IgG and IgG1 antibodies.
    Béla SR, Oliveira Silva DA, Cunha-Júnior JP, Pirovani CP, Chaves-Borges FA, Reis de Carvalho F, Carrijo de Oliveira T, Mineo JR.
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):245-54. PubMed ID: 18703303
    [Abstract] [Full Text] [Related]

  • 30. [Production and characterization of a panel of monoclonal antibodies to Toxoplasma gondii antigens].
    Poryvaeva VA, Aborneva IV, Bormotov NI, Gladkova SE, Reshetnikov SS, Kuvshinova IN, Rukavishnikov MIu, Dedkova LM, Belanov EF.
    Mol Gen Mikrobiol Virusol; 2003 Nov; (4):20-4. PubMed ID: 14664158
    [Abstract] [Full Text] [Related]

  • 31. Toxoplasma gondii: proteomic analysis of antigenicity of soluble tachyzoite antigen.
    Ma GY, Zhang JZ, Yin GR, Zhang JH, Meng XL, Zhao F.
    Exp Parasitol; 2009 May; 122(1):41-6. PubMed ID: 19545523
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Construction of monovalent and compound nucleic acid vaccines against Toxoplasma gondii with gene encoding p30].
    Yang TT, He SY, Jiang H, Gu QM, Cong H, Zhou HY, Zhang JQ, Li Y, Zhao QL.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb 28; 23(1):14-7. PubMed ID: 16042200
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Expression and bioactivity of S1 scFv antibody against SAG1 of Toxoplasma gondii fused with green fluorescent protein].
    Si J, Zhu YC, Cao LM, Wang XT, Liang YS, Guan XH.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Jun 28; 24(3):161-5. PubMed ID: 17094611
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Determination of the specificities of monoclonal and polyclonal antibodies to Neospora, Toxoplasma and Cryptosporidium by fluorescent antibody test (FAT).
    Latif BM, Jakubek EB.
    Trop Biomed; 2008 Dec 28; 25(3):225-31. PubMed ID: 19287361
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
    Golkar M, Shokrgozar MA, Rafati S, Musset K, Assmar M, Sadaie R, Cesbron-Delauw MF, Mercier C.
    Vaccine; 2007 May 22; 25(21):4301-11. PubMed ID: 17418457
    [Abstract] [Full Text] [Related]

  • 40. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
    Igarashi M, Kano F, Tamekuni K, Machado RZ, Navarro IT, Vidotto O, Vidotto MC, Garcia JL.
    Exp Parasitol; 2008 Mar 22; 118(3):386-92. PubMed ID: 18154953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.